This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grantab, R. Articles by Tannock, I. F. Search for Related Content PubMed PubMed Citation Articles by Grantab, R. Articles by Tannock, I. F.

The Penetration of Anticancer Drugs through Tumor Tissue as a Function of Cellular Adhesion and Packing Density of Tumor Cells

Division of Applied Molecular Oncology and Department of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada

Requests for reprints: Ian F. Tannock, Department of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9. Phone: 416-946-2245; Fax: 416-946-2082; E-mail: ian.tannock{at}uhn.on.ca.

To reach cancer cells in optimal quantities, therapeutic agents must be delivered to tumors through their imperfect blood vascular system, cross vessel walls into the interstitium, and penetrate multiple layers of tissue. Strategies to enhance drug penetration have potential to improve therapeutic outcome. The development of multicellular layers (MCLs), in which tumor cells are grown on a semipermeable Teflon support membrane, has facilitated quantification of drug penetration through solid tissue. The goals of the present study were to quantify the penetration of anticancer drugs as a function of cellular adhesion and packing density and to determine the effects of variable penetration on therapeutic efficacy in this model system. We compared the properties of MCLs grown from two epithelioid and round subclones of a colon carcinoma cell line. One pair of epithelioid and round sublines differed in expression of -E-catenin, and both pairs generated MCLs with different packing density. The penetration of commonly used anticancer agents (paclitaxel, doxorubicin, methotrexate, and 5-fluorouracil) through MCLs derived from these cell lines was significantly greater through the round (loosely packed) than through the epithelioid (tightly packed) sublines. In MCLs treated with doxorubicin, we observed greater survival in the tightly packed cell lines than in the loosely packed cell lines. Impaired penetration of anticancer agents through MCLs derived from the tightly packed cell lines and relative resistance to killing of cells within them by doxorubicin treatment strengthen the role of tumor cell adhesion and packing density as contributing to drug resistance. (Cancer Res 2006; 66(2): 1033-9)

This article has been cited by other articles:

				H. B. Frieboes, M. E. Edgerton, J. P. Fruehauf, F. R.A.J. Rose, L. K. Worrall, R. A. Gatenby, M. Ferrari, and V. Cristini Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling Cancer Res., May 15, 2009; 69(10): 4484 - 4492. [Abstract] [Full Text] [PDF]

				O. Tredan, C. M. Galmarini, K. Patel, and I. F. Tannock Drug Resistance and the Solid Tumor Microenvironment J Natl Cancer Inst, October 3, 2007; 99(19): 1441 - 1454. [Abstract] [Full Text] [PDF]

				A. H. Kyle, L. A. Huxham, D. M. Yeoman, and A. I. Minchinton Limited Tissue Penetration of Taxanes: A Mechanism for Resistance in Solid Tumors Clin. Cancer Res., May 1, 2007; 13(9): 2804 - 2810. [Abstract] [Full Text] [PDF]